So will it be:
1) a SMARTCOUGH-C-2 Study update; or
2) an Australian Paediatric Study update/preliminary results....that is the question!
On the latter, 230 patients were recruited in the double-blind study as of 4th Sept 2017. As far as I know, we have not had an update on this study since (other than a brief mention at the AGM).
So much riding on this guys. Mixed emotions for a lot of investors...some are +100% up from the lows, others (like myself) are still +50% down from July last year. But the build-up this time around has been good and I suspect there's a fair bit more upside to play out in the sp over the coming days/weeks/months.
RAP Price at posting:
17.5¢ Sentiment: Buy Disclosure: Held
